|
DDX59 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07309999999961E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.70119999993213E-07 |
| Normal-vs-Stage2 |
6.237100E-04 |
| Normal-vs-Stage3 |
1.333220E-01 |
| Normal-vs-Stage4 |
6.316800E-01 |
| Stage1-vs-Stage2 |
3.500000E-01 |
| Stage1-vs-Stage3 |
1.904160E-02 |
| Stage1-vs-Stage4 |
4.255200E-03 |
| Stage2-vs-Stage3 |
1.533600E-02 |
| Stage2-vs-Stage4 |
4.336600E-03 |
| Stage3-vs-Stage4 |
4.553800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32790000001637E-06 |
| Normal-vs-AfricanAmerican |
8.010600E-01 |
| Normal-vs-Asian |
2.869400E-01 |
| Caucasian-vs-AfricanAmerican |
3.159700E-02 |
| Caucasian-vs-Asian |
7.716400E-01 |
| AfricanAmerican-vs-Asian |
2.608200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.855020E-03 |
| Normal-vs-Female |
2.76320000003327E-06 |
| Male-vs-Female |
3.650500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.529600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.428700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.558600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.018400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.357400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.758400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.363600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.317600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.691400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.306000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.65710000166186E-08 |
| Normal-vs-Grade 2 |
1.51560000105633E-08 |
| Normal-vs-Grade 3 |
1.804200E-02 |
| Normal-vs-Grade 4 |
2.471200E-01 |
| Grade 1-vs-Grade 2 |
1.458630E-01 |
| Grade 1-vs-Grade 3 |
8.584000E-03 |
| Grade 1-vs-Grade 4 |
9.89489999999593E-05 |
| Grade 2-vs-Grade 3 |
2.200000E-03 |
| Grade 2-vs-Grade 4 |
8.25830000050765E-07 |
| Grade 3-vs-Grade 4 |
6.784100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
7.198000E-01 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.219740E-04 |
| Normal-vs-N1 |
9.799600E-01 |
| N0-vs-N1 |
1.978570E-01 |
|
|
